IL95441A0 - Peptide sequences and diagnostic uses thereof - Google Patents

Peptide sequences and diagnostic uses thereof

Info

Publication number
IL95441A0
IL95441A0 IL95441A IL9544190A IL95441A0 IL 95441 A0 IL95441 A0 IL 95441A0 IL 95441 A IL95441 A IL 95441A IL 9544190 A IL9544190 A IL 9544190A IL 95441 A0 IL95441 A0 IL 95441A0
Authority
IL
Israel
Prior art keywords
peptides
ras
val
arg
lev
Prior art date
Application number
IL95441A
Other languages
English (en)
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of IL95441A0 publication Critical patent/IL95441A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL95441A 1989-08-21 1990-08-21 Peptide sequences and diagnostic uses thereof IL95441A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39691089A 1989-08-21 1989-08-21

Publications (1)

Publication Number Publication Date
IL95441A0 true IL95441A0 (en) 1991-06-30

Family

ID=23569088

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95441A IL95441A0 (en) 1989-08-21 1990-08-21 Peptide sequences and diagnostic uses thereof

Country Status (8)

Country Link
EP (1) EP0491828B1 (de)
JP (1) JPH05500506A (de)
AT (1) ATE181332T1 (de)
AU (2) AU652724B2 (de)
CA (1) CA2065017A1 (de)
DE (1) DE69033166T2 (de)
IL (1) IL95441A0 (de)
WO (1) WO1991002749A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830684A (en) * 1988-08-10 1998-11-03 Chiron Corporation Native type II GAP, methods for purifying various GAPs and uses of GAPs to diagnose cancer
FR2690162B1 (fr) * 1992-04-21 1995-08-04 Rhone Poulenc Rorer Sa Peptides ayant une activite de facteur d'echange du gdp, sequences d'acides nucleiques codant pour ces peptides, preparation et utilisation.
FR2694296B1 (fr) * 1992-07-30 1994-09-02 Rhone Poulenc Rorer Sa Peptides inhibant l'activité des protéines ras, préparation et utilisation.
IL116026A (en) * 1994-11-22 2005-08-31 Rhone Poulenc Rorer Sa Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses
FR2734266B1 (fr) * 1995-05-16 1997-06-20 Rhone Poulenc Rorer Sa Peptides capables de se lier au domaine sh3 de la proteine gap sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
FR2727116B1 (fr) * 1994-11-22 1996-12-20 Rhone Poulenc Rorer Sa Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
US6312941B1 (en) * 1997-11-26 2001-11-06 The Regents Of The University Of Michigan Compositions and methods for identifying signaling pathway agonists and antagonists
AU2001279103A1 (en) * 2000-08-03 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer
CN114269918A (zh) * 2019-08-14 2022-04-01 摩登纳特斯有限公司 用于纯化体外转录的下游产物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466688B1 (de) * 1988-07-08 1997-08-06 Chiron Corporation Gap-gen-sequenzen und diagnoseverwendungen davon
EP0354808B1 (de) * 1988-08-12 1997-12-03 Ligand Pharmaceuticals Incorporated Polypeptid-induzierte monoklonale Rezeptoren gegen Proteinliganden
EP0407543A4 (en) * 1988-12-22 1992-10-14 Fishman, Mark C. Mammalian gap-43 compositions and methods of use

Also Published As

Publication number Publication date
JPH05500506A (ja) 1993-02-04
EP0491828A1 (de) 1992-07-01
DE69033166T2 (de) 1999-12-23
CA2065017A1 (en) 1991-02-22
EP0491828B1 (de) 1999-06-16
AU6424790A (en) 1991-04-03
DE69033166D1 (de) 1999-07-22
ATE181332T1 (de) 1999-07-15
AU652724B2 (en) 1994-09-08
WO1991002749A1 (en) 1991-03-07
AU8034694A (en) 1995-02-16

Similar Documents

Publication Publication Date Title
Manning et al. The regulatory components of adenylate cyclase and transducin. A family of structurally homologous guanine nucleotide-binding proteins.
Yu et al. Importance of FSH-releasing protein and inhibin in erythrodifferentiation
Adam et al. Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers
Monroe et al. B cell activation. I. Anti-immunoglobulin-induced receptor cross-linking results in a decrease in the plasma membrane potential of murine B lymphocytes.
EP0751962A4 (de) Methoden und zusammensetzungen für inhibition der cd14-abhängigen zellaktivierung
LaMorte et al. Inhibition of DNA synthesis in living cells by microinjection of Gi2 antibodies.
NO913211L (no) Nytt monoklonalt antistoff mot nytt antigen knyttet til menneske-tumorer.
IL95441A0 (en) Peptide sequences and diagnostic uses thereof
Jin et al. Regulation of EGF receptor signaling by the MARVEL domain-containing protein CKLFSF8
Barmore et al. Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding
DE69229394D1 (de) Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen
ATE151078T1 (de) Verfahren und zwischenprodukte synthetischer antikörperderivate
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
Zwirner et al. Complement activation in human lymphoid germinal centres
FI953525L (fi) Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi
Man et al. Mass spectrometric analysis of the glycosphingolipid‐enriched microdomains of rat natural killer cells
AU2497388A (en) Polypeptide-induced monoclonal receptors to protein ligand
Jackson et al. Identification of ε-N-trimethyllysine in a rat testis calcium-dependent regulatory protein of cyclic nucleotide phosphodiesterase
DE69626829D1 (de) Monoklonale antikörper gegen lösliche tnf-alpha rezeptoren p55 und p75 als auch gegen tnf-alpha und dessen analogen
Navon et al. Differences in metabolite levels upon differentiation of intact neuroblastoma× glioma cells observed by proton NMR spectroscopy
IL117157A0 (en) Preparation of factor ix from biological sources
WO1990000607A3 (en) Gap gene sequences and diagnostic uses thereof
Katagata et al. Occurrence and comparison of the expressed keratins in cultured human fibroblasts, endothelial cells and their sarcomas
Michaelsen Evidence of 15 S–S Bridges in the Hinge Region of Human 530
AU4114800A (en) Monoclonal antibodies against human protein mcm3, process for their production, and their use